Older Age at Diagnosis and Initial Disease Volume Predict Grade Reclassification Risk on Confirmatory Biopsy in Patients Considered for Active Surveillance-Reference-Cited by-同舟云学术

Older Age at Diagnosis and Initial Disease Volume Predict Grade Reclassification Risk on Confirmatory Biopsy in Patients Considered for Active Surveillance

Published:2019-08 Issue: Volume:130 Page:106-112
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Dai Charles,Ganesan Vishnu,Nyame Yaw A.,Almassi Nima,Greene Daniel J.,Hettel Daniel,Magi-Galluzzi Cristina,Gong Michael,Jones J. Stephen,Stephenson Andrew J.,Berglund Ryan K.,Klein Eric A.

Publisher

Elsevier BV

Subject

Urology

Reference31 articles.

1. Long-term follow-up of a large active surveillance cohort of patients with prostate cancer;Klotz;J Clin Oncol,2015

2. Intermediate and longer-term outcomes from a prospective active-surveillance program for favorable-risk prostate cancer;Tosoian;J Clin Oncol,2015

3. Pathologic prostate cancer characteristics in patients eligible for active surveillance: a head-to-head comparison of contemporary protocols;Iremashvili;Eur Urol,2012

4. A decade of active surveillance in the prias study: an update and evaluation of the criteria used to recommend a switch to active treatment;Bokhorst;Eur Urol,2016

5. Predictors of pathologic progression on biopsy among men on active surveillance for localized prostate cancer: the value of the pattern of surveillance biopsies;Cary;Eur Urol,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncological Outcomes in Men With Favorable Intermediate Risk Prostate Cancer Enrolled in Active Surveillance;In Vivo;2024

2. Aggressive Prostate Cancer in Patients Treated with Active Surveillance;Cancers;2023-08-25

3. Old men with prostate cancer have higher risk of Gleason score upgrading and pathological upstaging after initial diagnosis: a systematic review and meta-analysis;World Journal of Surgical Oncology;2021-01-20

4. Multiparametric magnetic resonance imaging and clinical variables: Which is the best combination to predict reclassification in active surveillance patients?;Prostate International;2020-12